Economic and Cost-Effectiveness Considerations for Pharmacogenetics Tests: An Integral Part of Translational Research and Innovation Uptake in Personalized Medicine

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|7|4|284-296

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.7, Iss.4, 2009-12, pp. : 284-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Effectiveness, Personalized Medicine and Innovation: The Path Forward

By Thomas Adrian  

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 923-930

Adis International

Access to resources Recommend Favorite

Personalized Medicine: Pharmacogenetics in Psychiatry

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 1, 2008-03 ,pp. : 1-11

Bentham Science Publishers

Access to resources Recommend Favorite

Warfarin Pharmacogenetics: Economic Considerations

By Hughes Dyfrig A.  

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 899-902

Adis International

Access to resources Recommend Favorite

Multiomics medicine in oncology: assessing effectiveness, cost–effectiveness and future research priorities for the molecularly unique individual

By Doble Brett   Harris Anthony   Thomas David M   Fox Stephen   Lorgelly Paula  

Pharmacogenomics, Vol. 14, Iss. 12, 2013-09 ,pp. : 1405-1417

Future Medicine

Access to resources Recommend Favorite

Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation

By Vernon John A.  

PharmacoEconomics, Vol. 27, Iss. 10, 2009-10 ,pp. : 797-806

Adis International

Access to resources Recommend Favorite